Switch theme
Sign up to access all valuation multiples
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, (i) development and contract manufacturing of generic dermatological solutions; and (ii) developing and formulating solutions to specific The Company operates in only one segment which is dealing in pharma products dermatological problem.
2017
84
Last FY Revenue $5.1M
Last FY EBITDA $2.0M
$17.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Amwill Healthcare achieved revenue of $5.1M and an EBITDA of $2.0M.
Amwill Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amwill Healthcare valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $5.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $3.7M | XXX | XXX | XXX |
| Gross Margin | XXX | 73% | XXX | XXX | XXX |
| EBITDA | XXX | $2.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 38% | XXX | XXX | XXX |
| EBIT | XXX | $1.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | 37% | XXX | XXX | XXX |
| Net Profit | XXX | $1.5M | XXX | XXX | XXX |
| Net Margin | XXX | 29% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amwill Healthcare's stock price is INR 82 (or $1).
Amwill Healthcare has current market cap of INR 1.6B (or $19.2M), and EV of INR 1.5B (or $17.7M).
See Amwill Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17.7M | $19.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amwill Healthcare has market cap of $19.2M and EV of $17.7M.
Amwill Healthcare's trades at 3.4x EV/Revenue multiple, and 9.0x EV/EBITDA.
Equity research analysts estimate Amwill Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amwill Healthcare's P/E ratio is not available.
See valuation multiples for Amwill Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19.2M | XXX | $19.2M | XXX | XXX | XXX |
| EV (current) | $17.7M | XXX | $17.7M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 9.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 13.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -38.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmwill Healthcare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $22K for the same period.
Amwill Healthcare's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amwill Healthcare's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amwill Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 38% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $22K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amwill Healthcare acquired XXX companies to date.
Last acquisition by Amwill Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Amwill Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amwill Healthcare founded? | Amwill Healthcare was founded in 2017. |
| Where is Amwill Healthcare headquartered? | Amwill Healthcare is headquartered in India. |
| How many employees does Amwill Healthcare have? | As of today, Amwill Healthcare has 84 employees. |
| Is Amwill Healthcare publicy listed? | Yes, Amwill Healthcare is a public company listed on BOM. |
| What is the stock symbol of Amwill Healthcare? | Amwill Healthcare trades under 544353 ticker. |
| When did Amwill Healthcare go public? | Amwill Healthcare went public in 2025. |
| Who are competitors of Amwill Healthcare? | Similar companies to Amwill Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Amwill Healthcare? | Amwill Healthcare's current market cap is $19.2M |
| Is Amwill Healthcare profitable? | Yes, Amwill Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
